|
BE615511A
(OSRAM)
|
1961-03-25 |
|
|
|
|
NL292958A
(OSRAM)
|
1962-05-29 |
1900-01-01 |
|
|
|
GB8809205D0
(en)
|
1988-04-19 |
1988-05-25 |
Nye P C G |
Treatment of oedema
|
|
US5137871A
(en)
|
1989-07-28 |
1992-08-11 |
Regents Of The University Of California |
Treatment to reduce edema for brain and musculature injuries
|
|
DE4010536A1
(de)
*
|
1990-04-02 |
1991-10-10 |
Boehringer Mannheim Gmbh |
Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure
|
|
US5486530A
(en)
|
1991-04-27 |
1996-01-23 |
Boehringer Mannheim Gmbh |
Use of torasemide for the treatment of brain oedemas
|
|
DE4113820A1
(de)
|
1991-04-27 |
1992-10-29 |
Boehringer Mannheim Gmbh |
Verwendung von torasemid zur behandlung von hirnoedemen
|
|
US5858702A
(en)
|
1991-12-13 |
1999-01-12 |
The Johns Hopkins University |
Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)
|
|
US5741671A
(en)
|
1991-12-12 |
1998-04-21 |
The Johns Hopkins University |
Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)
|
|
US5519035A
(en)
|
1993-07-02 |
1996-05-21 |
Cornell Research Foundation, Inc. |
Treatment of stroke or in anticipation of the occurrence of brain ischemia
|
|
US20060167110A1
(en)
|
1995-01-13 |
2006-07-27 |
Blume Cherly D |
Methods for treating cerebrovascular disease by administering desmethylselegiline
|
|
WO1998021951A1
(en)
|
1996-11-18 |
1998-05-28 |
Emisphere Technologies, Inc. |
Methods and compositions for inducing oral tolerance in mammals
|
|
JP2001513503A
(ja)
|
1997-08-06 |
2001-09-04 |
スミスクライン・ビーチャム・コーポレイション |
心臓血管系の疾病の治療に用いられるマクロファージスカベンジャー受容体アンタゴニスト
|
|
US5905090A
(en)
|
1998-04-29 |
1999-05-18 |
Italfarmaco S.P.A. |
Analogues of the active metabolite of leflunomide
|
|
CO5180581A1
(es)
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
|
US6500809B1
(en)
|
1999-11-12 |
2002-12-31 |
Neuron Therapeutics, Inc. |
Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
|
|
ATE257479T1
(de)
|
1999-12-10 |
2004-01-15 |
Pfizer |
5-ring heteroarylsubstituierte 1,4- dihydropyridine als bradykinin antagonisten
|
|
UA82827C2
(en)
|
2000-12-18 |
2008-05-26 |
|
Inhibitors against the production and release of inflammatory cytokines
|
|
US8980952B2
(en)
|
2002-03-20 |
2015-03-17 |
University Of Maryland, Baltimore |
Methods for treating brain swelling with a compound that blocks a non-selective cation channel
|
|
US7872048B2
(en)
|
2004-09-18 |
2011-01-18 |
University Of Maryland, Baltimore |
Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel
|
|
JP4485806B2
(ja)
|
2002-03-20 |
2010-06-23 |
ユニヴァーシティ オブ メリーランド，ボルチモア |
神経系細胞の非選択的陽イオンチャネルおよび脳腫脹を治療する方法
|
|
TWI280876B
(en)
|
2002-06-05 |
2007-05-11 |
Inst Med Molecular Design Inc |
Therapeutic drug for diabetes
|
|
AU2003242131A1
(en)
|
2002-06-05 |
2003-12-22 |
Institute Of Medicinal Molecular Design, Inc. |
Immunity-related protein kinase inhibitors
|
|
CA2487891A1
(en)
|
2002-06-05 |
2003-12-18 |
Institute Of Medicinal Molecular Design, Inc. |
Inhibitors against the activation of ap-1 and nfat
|
|
CN1658872B
(zh)
|
2002-06-06 |
2010-09-22 |
株式会社医药分子设计研究所 |
抗过敏药
|
|
KR20110028554A
(ko)
*
|
2002-06-06 |
2011-03-18 |
가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 |
Ｏ-치환 히드록시아릴 유도체
|
|
TW200307535A
(en)
|
2002-06-10 |
2003-12-16 |
Inst Med Molecular Design Inc |
Therapeutic agent for cancer
|
|
EA010470B1
(ru)
*
|
2002-06-10 |
2008-08-29 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
ИНГИБИТОРЫ АКТИВАЦИИ NF-kB
|
|
JP4635130B2
(ja)
|
2002-06-11 |
2011-02-16 |
株式会社医薬分子設計研究所 |
神経変性疾患治療剤
|
|
EP1542699A4
(en)
|
2002-07-15 |
2009-03-25 |
Myriad Genetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
|
|
DK1590458T3
(da)
|
2003-02-06 |
2013-02-04 |
Univ Belfast |
Bradykinin B2-receptorantagonistpeptid fra amfibiehud
|
|
NZ543201A
(en)
|
2003-05-01 |
2007-05-31 |
Innogene Kalbiotech Pte Ltd |
Lactate containing pharmaceutical composition and uses thereof
|
|
CN100406006C
(zh)
|
2003-07-16 |
2008-07-30 |
株式会社医药分子设计研究所 |
皮肤色素沉着的治疗剂
|
|
NZ546365A
(en)
|
2003-10-08 |
2010-01-29 |
Vertex Pharma |
Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups
|
|
US8467876B2
(en)
|
2003-10-15 |
2013-06-18 |
Rmx, Llc |
Breathing disorder detection and therapy delivery device and method
|
|
WO2005039556A1
(ja)
|
2003-10-29 |
2005-05-06 |
Institute Of Medicinal Molecular Design. Inc. |
血行再建術後の再狭窄又は再閉塞の治療及び／又は予防のための医薬
|
|
US7378509B2
(en)
|
2003-12-02 |
2008-05-27 |
Anesiva, Inc. |
NF-kappaB oligonucleotide decoy molecules
|
|
US10583094B2
(en)
|
2004-09-18 |
2020-03-10 |
University Of Maryland |
Therapeutic methods that target the NCCA-ATP channel
|
|
US7601745B2
(en)
|
2004-09-27 |
2009-10-13 |
4Sc Ag |
Heterocyclic NF-kB inhibitors
|
|
KR20070111475A
(ko)
|
2005-01-04 |
2007-11-21 |
노파르티스 아게 |
만성 변비 환자에서 테가세로드의 효능을 확인하기 위한바이오마커
|
|
TWI462745B
(zh)
*
|
2005-04-28 |
2014-12-01 |
Takeda Pharmaceutical |
安定的乳化組成物
|
|
WO2007084464A2
(en)
|
2006-01-17 |
2007-07-26 |
The University Of North Carolina At Chapel Hill |
Water channel blockers and methods of use thereof
|
|
JP4273235B2
(ja)
|
2006-06-01 |
2009-06-03 |
国立大学法人 新潟大学 |
アクアポリン４阻害薬
|
|
US20080014196A1
(en)
|
2006-06-06 |
2008-01-17 |
Genentech, Inc. |
Compositions and methods for modulating vascular development
|
|
AU2007319672B2
(en)
|
2006-06-06 |
2011-06-30 |
Genentech, Inc. |
Anti-DLL4 antibodies and methods using same
|
|
US7671058B2
(en)
|
2006-06-21 |
2010-03-02 |
Institute Of Medicinal Molecular Design, Inc. |
N-(3,4-disubstituted phenyl) salicylamide derivatives
|
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
|
WO2008046014A1
(en)
|
2006-10-12 |
2008-04-17 |
Remedy Pharmaceuticals, Inc. |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective ca++- activated atp-sensitive cation channels regulated by sur1 receptors
|
|
CA2669117A1
(en)
|
2006-10-26 |
2008-05-02 |
Gary A. Flynn |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
US9316633B2
(en)
*
|
2006-11-16 |
2016-04-19 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
|
US20080214486A1
(en)
|
2006-11-28 |
2008-09-04 |
Alcon Manufacturing, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
WO2008067373A2
(en)
|
2006-11-28 |
2008-06-05 |
Alcon Research, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
CA2674949A1
(en)
|
2007-01-12 |
2008-07-24 |
J. Marc Simard |
Targeting ncca-atp channel for organ protection following ischemic episode
|
|
TWI629058B
(zh)
|
2007-01-16 |
2018-07-11 |
陳建宏 |
醫藥組成物及其用途
|
|
US20120183600A1
(en)
*
|
2007-01-16 |
2012-07-19 |
Chien-Hung Chen |
Novel composition for treating metabolic syndrome and other conditions
|
|
EP2114160B1
(en)
|
2007-02-09 |
2016-11-16 |
University of Maryland, Baltimore |
Antagonists of a non-selective cation channel in neural cells
|
|
CA2678486C
(en)
|
2007-02-17 |
2019-03-12 |
President And Fellows Of Harvard College |
Compositions and method for tissue preservation
|
|
TW200848063A
(en)
|
2007-04-23 |
2008-12-16 |
Combinatorx Inc |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
CA2691199C
(en)
|
2007-06-22 |
2017-09-12 |
Marc J. Simard |
Inhibitors of ncca-atp channels for therapy
|
|
EP2178531A4
(en)
*
|
2007-07-02 |
2012-01-11 |
Yu Ming |
METHODS AND COMPOSITIONS, TARGETS FOR COMBINED CANCER TREATMENTS
|
|
US20090239868A1
(en)
|
2007-10-23 |
2009-09-24 |
Institute Of Medical Molecular Design, Inc. |
Inhibitor of pai-1 production
|
|
CN101842093B
(zh)
*
|
2007-10-23 |
2012-08-22 |
株式会社医药分子设计研究所 |
Pai-1产生抑制剂
|
|
PL2868315T3
(pl)
|
2007-12-04 |
2018-06-29 |
Biogen Chesapeake Llc |
Udoskonalone preparaty i sposoby liofilizacji oraz uzyskiwane liofilizaty
|
|
GB0724340D0
(en)
|
2007-12-13 |
2008-01-30 |
Univ Dundee |
Novel Therapeutic Agents
|
|
US8642660B2
(en)
*
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US20110034560A1
(en)
|
2008-01-29 |
2011-02-10 |
Sven Jacobson |
Liquid formulations of compounds active at sulfonylurea receptors
|
|
US8211882B2
(en)
*
|
2008-03-08 |
2012-07-03 |
Richard Delarey Wood |
Glutamate receptor modulators and therapeutic agents
|
|
WO2009139925A1
(en)
|
2008-05-16 |
2009-11-19 |
Panacea Pharmaceuticals, Inc. |
Methods for the treatment of brain edema
|
|
EP2719380A3
(en)
|
2008-09-16 |
2014-07-30 |
University of Maryland, Baltimore |
SUR1 inhibitors for therapy
|
|
US20120010178A1
(en)
|
2008-10-21 |
2012-01-12 |
President And Fellows Of Harvard College |
Methods and compounds for treatment of neurodegenerative disorders
|
|
GB0823366D0
(en)
|
2008-12-22 |
2009-01-28 |
Uni I Oslo |
Synthesis
|
|
EP2385935A4
(en)
|
2009-01-12 |
2014-11-05 |
Purapharm Company Ltd |
COMPOUNDS AND APPLICATIONS THEREFOR FOR TREATING INFLAMMATION AND FOR MODULATING IMMUNE REACTIONS
|
|
US20120039805A1
(en)
|
2009-02-20 |
2012-02-16 |
Pangea Biosciences, Inc. |
Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
|
|
MX2012010382A
(es)
|
2010-03-10 |
2013-01-29 |
Univ Melbourne |
Modulacion de acuaporinas con relaxina.
|
|
JP6188021B2
(ja)
|
2010-07-19 |
2017-08-30 |
バイオジェン チェサピーク エルエルシー |
グリブリドおよび他の薬剤の静脈内投与方法
|
|
EP2598145A1
(en)
*
|
2010-07-28 |
2013-06-05 |
Boehringer Ingelheim International GmbH |
Pharmaceutical composition for treatment of respiratory and inflammatory diseases
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
WO2012125749A2
(en)
|
2011-03-14 |
2012-09-20 |
Io Therapeutics, Inc. |
INFLAMMATION AND AUTOIMMUNE DISORDER TREATMENT USING RARα SELECTIVE AGONISTS
|
|
US9290765B2
(en)
*
|
2011-05-02 |
2016-03-22 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg |
Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (ARG)
|
|
RU2461375C1
(ru)
*
|
2011-05-19 |
2012-09-20 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ комбинированного лечения больных местно-распространенным раком желудка
|
|
WO2013152313A1
(en)
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
US9452973B2
(en)
|
2012-05-04 |
2016-09-27 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Modulators of the relaxin receptor 1
|
|
CA2872012C
(en)
|
2012-05-08 |
2017-06-20 |
Aeromics, Llc |
New methods
|
|
EP3045169B1
(en)
|
2013-09-13 |
2018-05-02 |
Akiko Itai |
Aqueous solution formulation, and manufacturing method for same
|
|
CN106163506A
(zh)
|
2013-11-06 |
2016-11-23 |
埃罗米克斯公司 |
新配方
|
|
SI3080134T1
(sl)
|
2013-12-13 |
2018-11-30 |
Vertex Pharmaceuticals Incorporated |
Predzdravila piridon amidov uporabna kot modulatorji natrijevih kanalov
|
|
AU2015346076A1
(en)
|
2014-11-13 |
2017-06-15 |
Aeromics, Inc. |
Novel methods
|
|
CN108348567B
(zh)
|
2015-05-29 |
2022-03-01 |
马里兰州立大学巴尔的摩分校 |
减少或预防由内皮细胞的机械刺激所致的内膜损伤的方法
|
|
MA45574A
(fr)
|
2015-10-07 |
2019-05-15 |
Biogen Chesapeake Llc |
Procédés de traitement de lésions ou de pathologies liées à un dème du snc
|
|
JP2019521086A
(ja)
|
2016-05-13 |
2019-07-25 |
エアロミクス・インコーポレイテッドＡｅｒｏｍｉｃｓ，Ｉｎｃ． |
結晶
|
|
KR102646250B1
(ko)
|
2016-07-29 |
2024-03-11 |
레메디 파마슈티칼즈, 인크. |
Sur1-trpm4 통로 저해제를 이용하는 의학적 치료 방법
|
|
BR112023002129A2
(pt)
|
2020-08-05 |
2023-04-18 |
Jiangsu Simcere Pharm Co Ltd |
Composição farmacêutica de inibidor de aquaporina e método de preparação da mesma
|